Cargando…

Peripheral endocannabinoids in eating disorders and obesity and its relationship with clinical and anthropometric variables

INTRODUCTION: Anandamide (AEA) and 2-Arachidonoylglycerol (2-AG) play a pivotal role in food intake and reward aspects of feeding. Aberrant functioning in the endocannabinoid system has been observed in patients with eating disorders (EDs). This dysfunction may influence the incentive processes stim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baenas-Soto, I., Miranda-Olivos, R., Vos, L., Granero, R., Sánchez, I., Riesco, N., Pino-Gutiérrez, A. Del, Codina, E., Fernández-Formoso, J. A., Vilarrasa, N., Virgili, N., Lopez-Urdiales, R., Pastor, A., De La Torrre, R., Jimenez-Murcia, S., Soriano-Mas, C., Fernandez-Aranda, F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2021
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470447/ http://dx.doi.org/10.1192/j.eurpsy.2021.329

Ejemplares similares

Nucleus accumbens functional connectivity and circulating endocannabinoids levels in anorexia nervosa
por: Miranda-Olivos, R., et al.
Publicado: (2022)

Association of anandamide and 2-arachidonoylglycerol concentrations with clinical features and body mass index in eating disorders and obesity
por: Baenas, Isabel, et al.
Publicado: (2023)

The neural correlates of delay discounting in obesity and binge eating disorder
por: Miranda-Olivos, Romina, et al.
Publicado: (2021)

How to assess severity in males with eating disorders? The DSM-5 severity index versus severity based on drive for thinness
por: Dang, A., et al.
Publicado: (2021)

A multimodal MRI study of the neural mechanisms of emotion regulation impairment in women with obesity
por: Steward, Trevor, et al.
Publicado: (2019)

Relationship between Signals Regulating Energy Homeostasis and Neuropsychological and Clinical Features in Gambling Disorder: A Case-Control Study
por: Fernandez-Aranda, F., et al.
Publicado: (2023)

Impact of COVID19 Lockdown in Eating Disorders: A Multicenter Collaborative International Study
por: Etxandi, M., et al.
Publicado: (2022)

Are Neurotrophin Genes Involved in the Pathophysiology of Gambling Disorder?
por: Baenas, I., et al.
Publicado: (2022)

Does ADHD Symptomatology Influence Treatment Outcome and Dropout Risk in Eating Disorders? A longitudinal Study
por: Testa, Giulia, et al.
Publicado: (2020)

What Difference Does it Make? Risk-Taking Behavior in Obesity after a Loss is Associated with Decreased Ventromedial Prefrontal Cortex Activity
por: Steward, Trevor, et al.
Publicado: (2019)

Emotional regulation in eating disorders and gambling disorder: A transdiagnostic approach
por: Munguía, Lucero, et al.
Publicado: (2021)

Food addiction and lifetime alcohol and illicit drugs use in specific eating disorders
por: Miranda-Olivos, Romina, et al.
Publicado: (2022)

Developmental trajectories of gambling severity after cognitive-behavioral therapy
por: Jimenez-Murcia, S., et al.
Publicado: (2022)

Predictors of Therapy Outcome in Eating Disorders: from Psychopathology to Personality
por: Fernandez-Aranda, F., et al.
Publicado: (2022)

Modulation of the Endocannabinoids N-Arachidonoylethanolamine (AEA) and 2-Arachidonoylglycerol (2-AG) on Executive Functions in Humans
por: Fagundo, Ana B., et al.
Publicado: (2013)

Treatment outcome of patients with comorbid type 1 diabetes and eating disorders
por: Custal, Nuria, et al.
Publicado: (2014)

Food Addiction in Eating Disorders and Obesity: Analysis of Clusters and Implications for Treatment
por: Jiménez-Murcia, Susana, et al.
Publicado: (2019)

The Role of Food Addiction and Lifetime Substance Use on Eating Disorder Treatment Outcomes
por: Miranda-Olivos, Romina, et al.
Publicado: (2023)

Does Confinement Affect Treatment Dropout Rates in Patients With Gambling Disorder? A Nine-Month Observational Study
por: Baenas, Isabel, et al.
Publicado: (2021)

Moderate-Vigorous Physical Activity across Body Mass Index in Females: Moderating Effect of Endocannabinoids and Temperament
por: Fernández-Aranda, Fernando, et al.
Publicado: (2014)

Cognitive flexibility and DSM-5 severity criteria for eating disorders: assessing drive for thinness and duration of illness as alternative severity variables
por: Mora-Maltas, Bernat, et al.
Publicado: (2023)

Neuropsychological Learning Deficits as Predictors of Treatment Outcome in Patients with Eating Disorders
por: Lucas, Ignacio, et al.
Publicado: (2021)

Are Signals Regulating Energy Homeostasis Related to Neuropsychological and Clinical Features of Gambling Disorder? A Case–Control Study
por: Etxandi, Mikel, et al.
Publicado: (2022)

Eating Disorders and Addictive Behaviors: Implications for Human Health
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Editorial: Neurological, psychological and endocrine markers of eating disorders and obesity
por: Fernández-Aranda, Fernando, et al.
Publicado: (2023)

Delay Discounting in Gambling Disorder: Implications in Treatment Outcome
por: Mena-Moreno, Teresa, et al.
Publicado: (2022)

Independent component analysis for internet gaming disorder
por: Mestre-Bach, Gemma, et al.
Publicado: (2023)

Lifetime Weight Course as a Phenotypic Marker of Severity and Therapeutic Response in Patients with Eating Disorders
por: Agüera, Zaida, et al.
Publicado: (2021)

Latent Classes for the Treatment Outcomes in Women with Gambling Disorder and Buying/Shopping Disorder
por: Granero, Roser, et al.
Publicado: (2022)

Impulsivity, Emotional Dysregulation and Executive Function Deficits Could Be Associated with Alcohol and Drug Abuse in Eating Disorders
por: Lozano-Madrid, María, et al.
Publicado: (2020)

Neural Network Alterations Across Eating Disorders: A Narrative Review of fMRI Studies
por: Steward, Trevor, et al.
Publicado: (2018)

Clustering Treatment Outcomes in Women with Gambling Disorder
por: Lara-Huallipe, Milagros Lizbeth, et al.
Publicado: (2021)

A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women
por: Pastor, Antoni, et al.
Publicado: (2016)

Dimensions of Compulsive Exercise across Eating Disorder Diagnostic Subtypes and the Validation of the Spanish Version of the Compulsive Exercise Test
por: Sauchelli, Sarah, et al.
Publicado: (2016)

Proapoptotic effect of endocannabinoids in prostate cancer cells
por: ORELLANA-SERRADELL, O., et al.
Publicado: (2015)

Underlying Mechanisms Involved in Gambling Disorder Severity: A Pathway Analysis Considering Genetic, Psychosocial, and Clinical Variables
por: Solé-Morata, Neus, et al.
Publicado: (2023)

Applying psycho-behavioural phenotyping in obesity characterization
por: Camacho-Barcia, Lucía, et al.
Publicado: (2023)

Do attention-deficit/hyperactivity symptoms influence treatment outcome in gambling disorder?
por: Vintró-Alcaraz, C., et al.
Publicado: (2023)

Corrigendum: Validation of the Spanish Version of the Yale Food Addiction Scale 2.0 (YFAS 2.0) and Clinical Correlates in a Sample of Eating Disorder, Gambling Disorder and Healthy Control Participants
por: Granero, Roser, et al.
Publicado: (2018)

Validation of the Spanish Version of the Yale Food Addiction Scale 2.0 (YFAS 2.0) and Clinical Correlates in a Sample of Eating Disorder, Gambling Disorder, and Healthy Control Participants
por: Granero, Roser, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_us02cgo4st4vmknisrli3g9g9s